HealthEquity, Inc. $HQY Stock Purchased by Tectonic Advisors LLC

Tectonic Advisors LLC increased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 9.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 109,953 shares of the company’s stock after acquiring an additional 9,630 shares during the period. Tectonic Advisors LLC’s holdings in HealthEquity were worth $9,726,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Root Financial Partners LLC purchased a new stake in shares of HealthEquity during the third quarter valued at approximately $58,000. Integrated Advisors Network LLC purchased a new position in shares of HealthEquity in the third quarter worth $323,000. Abel Hall LLC increased its stake in shares of HealthEquity by 3.8% in the third quarter. Abel Hall LLC now owns 6,736 shares of the company’s stock worth $596,000 after buying an additional 247 shares during the period. Counterpoint Mutual Funds LLC purchased a new stake in HealthEquity during the 3rd quarter valued at $604,000. Finally, Assenagon Asset Management S.A. boosted its position in HealthEquity by 54.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 32,776 shares of the company’s stock valued at $2,899,000 after buying an additional 11,561 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Adrian Dillon sold 7,632 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the sale, the director directly owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. This trade represents a 10.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.60% of the company’s stock.

HealthEquity Trading Up 3.0%

HQY stock traded up $3.00 on Friday, reaching $103.97. The company’s stock had a trading volume of 1,020,236 shares, compared to its average volume of 844,142. The business has a fifty day simple moving average of $95.36 and a two-hundred day simple moving average of $91.92. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62. The firm has a market cap of $8.60 billion, a PE ratio of 37.53, a PEG ratio of 1.59 and a beta of 0.24. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.05. The business had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company’s revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, research analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Raymond James Financial reaffirmed a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. Telsey Advisory Group set a $111.00 target price on HealthEquity in a research note on Friday, August 28th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a research note on Monday, August 31st. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, October 10th. Finally, BTIG Research reaffirmed a “buy” rating and set a $115.00 price target on shares of HealthEquity in a research report on Friday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus target price of $113.53.

About HealthEquity

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.